Valued at $172.0M at its later-stage round, Dec 2025. Nothing has traded since.
- ·The complete investor list: 22 names
- ·Watch Aeovian Pharmaceuticals: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Aeovian Pharmaceuticals funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2025 | Later Stage VC | $55.0M | ▮ | ▮ |
| Dec 2023 | Later Stage VC | $50.4M | ▮ | ▮ |
| Sep 2019 | Early Stage VC | $18.8M | ▮ | ▮ |
Membership and data by Private Market View
Aeovian Pharmaceuticals valuation
Aeovian Pharmaceuticals was valued at $172 million at its later-stage round in Dec 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Aeovian Pharmaceuticals raised?
Aeovian Pharmaceuticals has raised $143 million across 3 recorded rounds since 2019. The largest was a $55 million later-stage round in Nov 2025.
Aeovian Pharmaceuticals has filed 3 Form Ds with the SEC since 2019, most recently in Dec 2025 ($55 million sold to 13 investors).
How Aeovian Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Aeovian Pharmaceuticals, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Aeovian Pharmaceuticals
- What is Aeovian Pharmaceuticals worth?
- Aeovian Pharmaceuticals is valued at $172.0M as of Oct 2026. Valued at $172.0M at its later-stage round, Dec 2025. Nothing has traded since.
- How much has Aeovian Pharmaceuticals raised?
- Aeovian Pharmaceuticals has raised $143.2M in total funding across 3 recorded rounds.
- When did Aeovian Pharmaceuticals last raise?
- Aeovian Pharmaceuticals last raised in Nov 2025 (Later Stage VC), raising $55.0M.